● 2013年業績

Takayama K, Nagamoto Y, Mimura N, Tashiro K, Sakurai F, Tachibana M, Hayakawa T, Kawabata K, Mizuguchi H. Long-Term Self-Renewal of Human ES/iPS-Derived Hepatoblast-like Cells on Human Laminin 111-Coated Dishes.Stem Cell Reports, 1, 322-335 (2013)

Takayama K, Kawabata K, Inamura M, Ohashi K, Nagamoto Y, Okuno H, Yamaguchi T, Tashiro K, Sakurai F, Hayakawa T, Furue-Kusuda M, Mizuguchi H. CCAAT/enhancer binding protein-mediated regulation of TGFβ receptor 2 expression determine the hepatoblast fate decision.Development, in press.

Matsuura M, Somboonthum P, Murakami K, Ota M, Shoji M, Kawabata K, Mizuguchi H, Gomi Y, Yamanishi K, Mori Y. Novel polyvalent live vaccine against varicella-zoster and mumps virus infections.Microbiol Immunol., 57, 704-714 (2013)

山口朋子、川端健二； ｉＰＳ細胞由来マスト細胞を用いた難治性疾患の新規治療薬開発へ向けて、Biophilia、Vol.2 No.3、21-25 (2013)

Takayama K., Kawabata K., Nagamoto Y., Kishimoto K., Tashiro K., Sakurai F., Tachibana M., Kanda K., Hayakawa T., Furue MK., Mizuguchi H. 3D spheroid culture of hESC/hiPSC-derived hepatocyte-like cells for drug toxicity testing. Biomaterials, 34: 1781-1789 (2013)

Yamaguchi T., Tashiro K., Tanaka S., Katayama S., Ishida W., Fukuda K., Fukushima A., Araki R., Abe M., Mizuguchi H., Kawabata K. Two-step differentiation of mast cells from induced pluripotent stem cells. Stem Cells Dev., 22: 726-734 (2013)

＜業績のページへ＞